GGrantScoutHQCreate alert

Industry funding

Research & Science grants — Page 19

Scientific research, laboratories, discovery, data and research infrastructure awards. Results combine structured categories with topic evidence from the listing and may overlap with related industries.

781 current opportunities · showing 433–456

OPENHealth & Medical

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to identify modifiable mechanisms and therapeutic targets to address central nervous system (CNS) complications associated with human immunodeficiency virus (HIV). The initiative supports a phased research approach beginning with the identi

Deadline
Oct 29, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were

Deadline
Nov 6, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

National Institutes of Health

The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and be

Deadline
Nov 6, 2027
Funding
Up to $1,500,000
Check fit and official source →
OPENHealth & Medical

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

National Institutes of Health

The Theories, Models and Methods (TMM) initiative will support the development of computational tools for understanding dynamic brain circuits that are made broadly accessible to the greater research community. This program supports applications focused on tool building and dissemination in the doma

Deadline
Nov 9, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)

National Institutes of Health

The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an e

Deadline
Nov 13, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

National Institutes of Health

The objective of the NIA Academic Leadership Career Award (K07) is to provide support for established investigators who have the expertise and leadership skills to enhance aging and/or Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD)research capacity within their academi

Deadline
Nov 13, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

National Institutes of Health

The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an e

Deadline
Nov 13, 2027
Funding
See official notice
Check fit and official source →
OPENDisability & Accessibility

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observ

Deadline
Nov 16, 2027
Funding
Up to $6,250,000
Check fit and official source →
OPENHealth & Medical

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics

Deadline
Nov 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

National Institutes of Health

This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may b

Deadline
Nov 17, 2027
Funding
Estimated total program funding: $200,000
Check fit and official source →
OPENHealth & Medical

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biolo

Deadline
Nov 17, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to elucidate a role for understudied proteins in rare disease. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s). A list of eligible proteins i

Deadline
Nov 17, 2027
Funding
Up to $100,000
Check fit and official source →
OPENHealth & Medical

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

National Institutes of Health

This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may b

Deadline
Nov 17, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. These priorities were most recently outlined by the NIH Office of AIDS Research (OAR)

Deadline
Nov 17, 2027
Funding
See official notice
Check fit and official source →
OPENResearch & Science

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

National Institutes of Health

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support

Deadline
Nov 19, 2027
Funding
Estimated total program funding: $300,000
Check fit and official source →
OPENResearch & Science

DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH

Dept of the Army -- Materiel Command

The purpose of this combined Broad Agency Announcement (BAA) under Federal Acquisition Regulation (FAR) Part 35 and Funding Opportunity Announcement (FOA) under 2 Code of Federal Regulations (CFR) 200.204 (henceforth referred to as “BAA”) is to solicit research proposals for submission t

Deadline
Nov 21, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this Notice of Opportunity Announcement (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescri

Deadline
Dec 4, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription

Deadline
Dec 4, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
Up to $350,000
Check fit and official source →
OPENHealth & Medical

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
See official notice
Check fit and official source →
OPENClimate & Environment

NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements

National Park Service

The National Park Service (NPS) are seeking applications for Master Cooperative Agreements from CESU network participants in the following CESU network regions: North and West Alaska Californian Chesapeake Watershed Colorado Plateau Desert Southwest Great Basin Great Lakes Northern Forest Great Plai

Deadline
Jan 1, 2028
Funding
See official notice
Check fit and official source →

Build a stronger shortlist

First confirm that your legal entity is an eligible applicant. Then check whether the proposed work, geography, award size and project period align with the current official notice. Industry relevance alone is not eligibility.